Get started

Shortsqueeze

Weekly BTC-USD(26th July)BTC started the week of July 19th to 25th with the bearish movement, falling to the low of $29,300 on July 0th, however, a strong pullback rally followed and helped BTC to close the week in the green territory and formed a big bullish engulfing candle to close the week with 11% gain at $35,428. At the time of writing, BTC is trading slightly above $38,200. This strong upward rally is most likely triggered by the massive short liquidation streak, in fact, it spiked to about $48K on Binance futures as over $100 Million of short positions were wiped off. However, BTC is still trading in its horizontal channel and it has to sustain above $41K that will act as a confirmation of trend reversal. Even after this 17% gain, the major trend of BTC is still bearish. BTC is currently above 0.786 Fibonacci retracement level which is placed around $35K and also its 50-DEMA is also present in this range, therefore, the range of $34.5k to $35k will act as the nearest support level followed by the next support at $32.5K and $30K. On the higher side, BTC is facing selling pressure from the upper band of the channel which is placed at $39.7K to $41K, also, its 100-DEMA which is placed at $38.6K is also acting as an immediate resistance, once we get a decisive breakout from this range and BTC starts sustaining above $41K, this will act as a confirmation to go long for the next wave. On the plus side, Daily RSI has given a fresh breakout from its trendline resistance which it was respecting from past January 2021. Weekly MACD is also suggesting a trend reversal as it is trying to enter the positive territory. This depicts that the trend reversal can be expected in the coming days but a confirmation would be required to conclusively suggest that trend has reversed.
COINBASE:BTCUSD
by TradeDog-Research
Risk vs. Reward on 1-year investment hereGann analysis. getting close to major phycological breakout area. Risk captured in red and Reward captured in green. 2021 PT of $12-20. Fundamental snapshot: Many catalysts ahead for VBI vaccines. HBV therapeutic is said to be a potential blockbuster, with sales in the BILLIONS. Data from Brii high dose cohort expected Q1 2021 (current quarter), also Covid program could mark major milestone for the company as it is considered a great use case for their eVLP technology. Furthermore, the company received over $30 mill from CEPI for development of a Covid vaccine that worked for S. Africa variant know as VBI-2905 today, 3/10/2021 and it now shows on the company website HERE that VBIV has been working a suite of multivalent coronavirus vaccines coming. Note, multivalent is new and pan-corona virus candidate still expected to begin ph.1/2 later in 2021. Very exciting times to be in VBIV! Disclosure : I am long vbiv and not a financial advisor. this information is strictly educational and is not intended to be considered financial advice.
VLong
by follow_the_money